000018525 000__ 01253cam\a22003255i\4500
000018525 001__ 18525
000018525 003__ SzGeWIPO
000018525 005__ 20230421154734.0
000018525 008__ 910328s1986\\\\sz\\\\\\r\\\\u000\0\eng\d
000018525 035__ $$a(wipo)(CD )89/0531
000018525 035__ $$a(OCoLC)1159468182
000018525 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000018525 041__ $$aeng
000018525 084__ $$aE 2314G25 WIPO.BIOT (F/E)
000018525 090__ $$c19591$$d19591
000018525 1102_ $$aWorld Intellectual Property Organization
000018525 24510 $$aQuestionnaire concerning the legal protection of biotechnological inventions.
000018525 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c1986-
000018525 300__ $$a1 volume (various paging) ;$$c[28] cm
000018525 336__ $$atext$$btxt$$2rdacontent
000018525 337__ $$aunmediated$$bn$$2rdamedia
000018525 338__ $$avolume$$bnc$$2rdacarrier
000018525 500__ $$a(F/E/) : French and English version; See French version in QUESTIONNAIRE SUR LA PROTECTION JURIDIQUE DES INVENTIONS BIOTECHNOLOGIQUES; The full text of the conclusions of the Committee of Experts (document No E 2314g25 OMPI.BIOT/CE/II/3, Paragraphs 85-90) is reproduced in the Annex;.
000018525 650_0 $$aPatents.
000018525 650_0 $$aIntellectual property.
000018525 650_4 $$aWIPO AND UPOV DOCUMENTS : BIRPI : PARIS UNION : COMMITTEES OF EXPERTS, CONFERENCES, VARIOUS CONGRESSES
000018525 650_4 $$aPATENTS : PHARMACEUTICAL PRODUCTS
000018525 903_0 $$aBIOT/Q1-Q2$$v1
000018525 942__ $$cDOC
000018525 952__ $$w2006-11-03$$p1989-0531$$r0.00$$u23897$$bMAIN$$10$$kE 2314G25 WIPO.BIOT (F/E)$$v1991-03-28$$ztagged$$71
000018525 980__ $$aBIB
000018525 999__ $$c19591$$d19591